statements regarding our plans to offer access to compounded GLP-1s if a provider determines that a compounded product is clinically necessary and the expectation that such customer set will be limited
Reduced appetite = reduced intake = increased risk of missing key nutrients like: Protein Iron, calcium, magnesium, zinc, potassium, choline, folate
But the data doesnt back up that claim, Ramachandran said
Medication wastage and cost : Using medications outside their licensed indications may not be covered by NHS prescribing, leading to out-of-pocket expenses for patients
References Glucagon-like peptide 1-based therapies for the treatment of type 2 diabetes mellitus UpToDate accessed 5/11/24 GLP-1 receptor agonists | Prescribing information | Diabetes type 2 | CKS | NICE Bydureon 2 mg prolonged release suspension for injection in pre-filled pen (BCise) Summary of Product Characteristics (SmPC) (emc) Victoza 6 mg/ml solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) TRULICITY 1.5 mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) Ozempic 0.25 mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) Mounjaro KwikPen 10mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc)
